vs

Side-by-side financial comparison of Ally Financial Inc. (ALLY) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.

Ally Financial Inc. is the larger business by last-quarter revenue ($301.0M vs $158.6M, roughly 1.9× Stoke Therapeutics, Inc.). Ally Financial Inc. runs the higher net margin — 108.6% vs 71.2%, a 37.5% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -3.2%).

Ally Financial Inc. is an American bank holding company incorporated in Delaware and headquartered at Ally Detroit Center in Detroit, Michigan. The company provides financial services including car finance, online banking via a direct bank, corporate lending, vehicle insurance, mortgage loans, and other related financing services such as installment sale and lease agreements.

Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.

ALLY vs STOK — Head-to-Head

Bigger by revenue
ALLY
ALLY
1.9× larger
ALLY
$301.0M
$158.6M
STOK
Growing faster (revenue YoY)
STOK
STOK
+3664.3% gap
STOK
3661.1%
-3.2%
ALLY
Higher net margin
ALLY
ALLY
37.5% more per $
ALLY
108.6%
71.2%
STOK

Income Statement — Q4 FY2025 vs Q1 FY2025

Metric
ALLY
ALLY
STOK
STOK
Revenue
$301.0M
$158.6M
Net Profit
$327.0M
$112.9M
Gross Margin
Operating Margin
70.2%
Net Margin
108.6%
71.2%
Revenue YoY
-3.2%
3661.1%
Net Profit YoY
333.6%
528.0%
EPS (diluted)
$0.97
$1.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALLY
ALLY
STOK
STOK
Q4 25
$301.0M
Q3 25
$308.0M
Q2 25
$312.0M
Q1 25
$323.0M
$158.6M
Q4 24
$311.0M
$22.6M
Q3 24
$319.0M
Q2 24
$324.0M
Q1 24
$244.0M
Net Profit
ALLY
ALLY
STOK
STOK
Q4 25
$327.0M
Q3 25
$398.0M
Q2 25
$352.0M
Q1 25
$-225.0M
$112.9M
Q4 24
$-140.0M
$-10.5M
Q3 24
$357.0M
Q2 24
$294.0M
Q1 24
$157.0M
Operating Margin
ALLY
ALLY
STOK
STOK
Q4 25
Q3 25
Q2 25
Q1 25
-87.9%
70.2%
Q4 24
56.3%
-60.4%
Q3 24
73.0%
Q2 24
79.3%
Q1 24
70.1%
Net Margin
ALLY
ALLY
STOK
STOK
Q4 25
108.6%
Q3 25
129.2%
Q2 25
112.8%
Q1 25
-69.7%
71.2%
Q4 24
-45.0%
-46.4%
Q3 24
111.9%
Q2 24
90.7%
Q1 24
64.3%
EPS (diluted)
ALLY
ALLY
STOK
STOK
Q4 25
$0.97
Q3 25
$1.18
Q2 25
$1.04
Q1 25
$-0.82
$1.90
Q4 24
$-0.54
$-0.15
Q3 24
$1.06
Q2 24
$0.86
Q1 24
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALLY
ALLY
STOK
STOK
Cash + ST InvestmentsLiquidity on hand
$10.0B
$274.8M
Total DebtLower is stronger
$17.1B
Stockholders' EquityBook value
$15.5B
$350.1M
Total Assets
$196.0B
$406.9M
Debt / EquityLower = less leverage
1.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALLY
ALLY
STOK
STOK
Q4 25
$10.0B
Q3 25
$10.2B
Q2 25
$10.6B
Q1 25
$10.4B
$274.8M
Q4 24
$10.3B
$128.0M
Q3 24
$8.6B
Q2 24
$7.4B
Q1 24
$8.2B
Total Debt
ALLY
ALLY
STOK
STOK
Q4 25
$17.1B
Q3 25
$16.7B
Q2 25
$15.9B
Q1 25
$16.5B
Q4 24
$17.5B
Q3 24
$16.8B
Q2 24
$16.0B
Q1 24
$17.0B
Stockholders' Equity
ALLY
ALLY
STOK
STOK
Q4 25
$15.5B
Q3 25
$15.1B
Q2 25
$14.5B
Q1 25
$14.2B
$350.1M
Q4 24
$13.9B
$229.0M
Q3 24
$14.7B
Q2 24
$13.9B
Q1 24
$13.7B
Total Assets
ALLY
ALLY
STOK
STOK
Q4 25
$196.0B
Q3 25
$191.7B
Q2 25
$189.5B
Q1 25
$193.3B
$406.9M
Q4 24
$191.8B
$271.6M
Q3 24
$193.0B
Q2 24
$192.5B
Q1 24
$192.9B
Debt / Equity
ALLY
ALLY
STOK
STOK
Q4 25
1.10×
Q3 25
1.11×
Q2 25
1.09×
Q1 25
1.16×
Q4 24
1.26×
Q3 24
1.14×
Q2 24
1.15×
Q1 24
1.25×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALLY
ALLY
STOK
STOK
Operating Cash FlowLast quarter
$640.0M
$131.8M
Free Cash FlowOCF − Capex
$131.7M
FCF MarginFCF / Revenue
83.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.96×
1.17×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALLY
ALLY
STOK
STOK
Q4 25
$640.0M
Q3 25
$1.2B
Q2 25
$947.0M
Q1 25
$940.0M
$131.8M
Q4 24
$620.0M
$-23.2M
Q3 24
$992.0M
Q2 24
$1.6B
Q1 24
$1.3B
Free Cash Flow
ALLY
ALLY
STOK
STOK
Q4 25
Q3 25
Q2 25
Q1 25
$131.7M
Q4 24
$-23.2M
Q3 24
Q2 24
Q1 24
FCF Margin
ALLY
ALLY
STOK
STOK
Q4 25
Q3 25
Q2 25
Q1 25
83.0%
Q4 24
-102.7%
Q3 24
Q2 24
Q1 24
Capex Intensity
ALLY
ALLY
STOK
STOK
Q4 25
Q3 25
Q2 25
Q1 25
0.1%
Q4 24
0.2%
Q3 24
Q2 24
Q1 24
Cash Conversion
ALLY
ALLY
STOK
STOK
Q4 25
1.96×
Q3 25
3.02×
Q2 25
2.69×
Q1 25
1.17×
Q4 24
Q3 24
2.78×
Q2 24
5.36×
Q1 24
8.54×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALLY
ALLY

Noninsurance Contracts$242.0M80%
Brokerage Commissionsand Other$21.0M7%
Commercial Portfolio Segment$19.0M6%
Other$13.0M4%
Banking Fees And Interchange Income$5.0M2%
Brokered Agent Commissions$1.0M0%

STOK
STOK

Segment breakdown not available.

Related Comparisons